drugset / Trial / NCT06035861

Endothelial Cell Activation and Total Pulmonary Resistance in PAH

NCT06035861

Not yet recruiting 6 enrolled Imperial College London
NaSingle-groupOpen-labelBasic science

Summary

To determine whether changes in endothelial cell dysfunction are associated with changes in total pulmonary resistance in patients with pulmonary arterial hypertension

Timeline

Start
2026-08-01
Primary completion
2026-10-31
Completion
2026-10-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Emapunil Small molecule 90 mg